Skip to main content

Table 2 Assessment schedule

From: Protocol of a monocentric, double-blind, randomized, superiority, controlled trial evaluating the effect of in-prison OROS-methylphenidate vs. placebo treatment in detained people with attention-deficit hyperactivity disorder (BATIR)

Back to article page

Trials

ISSN: 1745-6215